STEFANIE MAYER: Open Payments
NPI 1003067786 · BOCA RATON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,197 in 138 payments from 22 companies in 2025. Trend: 2023 $3,277 · 2024 $3,173 · 2025 $3,197
Food & beverage: $3,102Education: $95
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 10 | $441 |
| ABBVIE INC. | 15 | $391 |
| Incyte Corporation | 11 | $370 |
| Galderma Laboratories, L.P. | 17 | $267 |
| Regeneron Healthcare Solutions, Inc. | 8 | $226 |
| Amgen Inc. | 11 | $220 |
| Janssen Biotech, Inc. | 6 | $195 |
| UCB, Inc. | 7 | $187 |
| Almirall LLC | 6 | $169 |
| Arcutis Biotherapeutics, Inc. | 19 | $169 |
Products named: DUPIXENT, OPZELURA, SKYRIZI, OTEZLA, TREMFYA, Bimzelx, Seysara, Zoryve.
Industry payments across FL — which companies pay providers there.
